Zamorano, JL, Lancellotti, P, Rodriguez Muñoz, D, Aboyans, V, Asteggiano, R, Galderisi, M, Habib, G, Lenihan, DJ, Lip, GYH, Lyon, AR, Lopez Fernandez, T, Mohty, D, Piepoli, MF, Tamargo, J, Torbicki, A, Suter, TM, Achenbach, S, Agewall, S, Badimon, L, Barón-Esquivias, G, Baumgartner, H, Bax, JJ, Bueno, H, Carerj, S, Dean, V, Erol, Ç
, Fitzsimons, D, Gaemperli, O, Kirchhof, P, Kolh, P, Nihoyannopoulos, P, Ponikowski, P, Roffi, M, Vaz Carneiro, A, Windecker, S, Minotti, G, Cardinale, D, Curigliano, G, De Azambuja, E, Dent, S, Ero, C, Ewer, MS, Farmakis, D, Fietkau, R, Kohl, P, McGale, P, Ringwald, J, Schulz-Menger, J, Stebbing, J, Steiner, RK & Szmit, S 2016, '
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines',
European Heart Journal, vol. 37, no. 36, pp. 2768-2801.
https://doi.org/10.1093/eurheartj/ehw211